On June 1, China’s Ministry of Science and Technology (the “MOST”) issued the long-awaited Implementing Rules on the Administrative Regulations on Human Genetic Resources (the “Implementing Rules”). A June 7 article by Pink Sheet Pharma Intelligence reviews the areas of tightened oversight, featuring insights from life sciences partner Katherine Wang (Shanghai).
“I think the implementation of the data privacy and cybersecurity regulations will likely pose more challenges to foreign life sciences companies’ operations in China,” Katherine stated in the piece.
Ropes & Gray’s client alert co-authored by Katherine Wang on the MOST’s Implementing Rules, outlining the six most noteworthy updates, can be reviewed here.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.